Detalhe da pesquisa
1.
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.
Am J Respir Crit Care Med
; 202(3): 433-447, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320621
2.
Letter from Singapore: Thirty years of progress in clinical care and research.
Respirology
; 28(10): 966-968, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648425
3.
Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in Singapore.
BMC Pulm Med
; 18(1): 85, 2018 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788943
4.
Letter from Singapore: The clinical and research response to COVID-19.
Respirology
; 25(10): 1101-1102, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808426
5.
Neisseria species as pathobionts in bronchiectasis.
Cell Host Microbe
; 30(9): 1311-1327.e8, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108613
6.
Palliative Rehabilitation Improves Health Care Utilization and Function in Frail Older Adults with Chronic Lung Diseases.
J Am Med Dir Assoc
; 22(12): 2478-2485.e1, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153233
7.
Association between lung compliance phenotypes and mortality in COVID-19 patients with acute respiratory distress syndrome.
Ann Acad Med Singap
; 50(9): 686-694, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625756
8.
Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore.
Sci Rep
; 11(1): 7477, 2021 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33820944
9.
An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis.
Int J Pharm
; 559: 382-392, 2019 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30731256
10.
A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
Int J Pharm
; 547(1-2): 368-376, 2018 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29886096